Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

53 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinicopathologic Features and Immune Microenvironment of Non-Small-cell Lung Cancer With Primary Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors.
Takashima Y, Sakakibara-Konishi J, Hatanaka Y, Hatanaka KC, Ohhara Y, Oizumi S, Hida Y, Kaga K, Kinoshita I, Dosaka-Akita H, Matsuno Y, Nishimura M. Takashima Y, et al. Clin Lung Cancer. 2018 Jul;19(4):352-359.e1. doi: 10.1016/j.cllc.2018.02.004. Epub 2018 Feb 19. Clin Lung Cancer. 2018. PMID: 29544718 Free article.
Numb has distinct function in lung adenocarcinoma and squamous cell carcinoma.
Kikuchi H, Sakakibara-Konishi J, Furuta M, Kikuchi E, Kikuchi J, Oizumi S, Hida Y, Kaga K, Kinoshita I, Dosaka-Akita H, Nishimura M. Kikuchi H, et al. Oncotarget. 2018 Jun 29;9(50):29379-29391. doi: 10.18632/oncotarget.25585. eCollection 2018 Jun 29. Oncotarget. 2018. PMID: 30034624 Free PMC article.
Bromodomain and extraterminal domain inhibition synergizes with WEE1-inhibitor AZD1775 effect by impairing nonhomologous end joining and enhancing DNA damage in nonsmall cell lung cancer.
Takashima Y, Kikuchi E, Kikuchi J, Suzuki M, Kikuchi H, Maeda M, Shoji T, Furuta M, Kinoshita I, Dosaka-Akita H, Sakakibara-Konishi J, Konno S. Takashima Y, et al. Int J Cancer. 2020 Feb 15;146(4):1114-1124. doi: 10.1002/ijc.32515. Epub 2019 Jun 28. Int J Cancer. 2020. PMID: 31199520 Free article.
Evaluating the immunoproteasome as a potential therapeutic target in cisplatin-resistant small cell and non-small cell lung cancer.
Shoji T, Kikuchi E, Kikuchi J, Takashima Y, Furuta M, Takahashi H, Tsuji K, Maeda M, Kinoshita I, Dosaka-Akita H, Sakakibara-Konishi J, Konno S. Shoji T, et al. Cancer Chemother Pharmacol. 2020 May;85(5):843-853. doi: 10.1007/s00280-020-04061-9. Epub 2020 Mar 30. Cancer Chemother Pharmacol. 2020. PMID: 32232513 Free article.
A case of radio-insensitive SMARCA4-deficient thoracic undifferentiated carcinoma with severe right heart failure.
Ito S, Asahina H, Yamaguchi N, Tomaru U, Hasegawa T, Hatanaka Y, Hatanaka KC, Taguchi H, Harada T, Ohira H, Ikeda D, Mizugaki H, Kikuchi E, Kikuchi J, Sakakibara-Konishi J, Shinagawa N, Konno S. Ito S, et al. Respir Med Case Rep. 2021 Feb 18;32:101364. doi: 10.1016/j.rmcr.2021.101364. eCollection 2021. Respir Med Case Rep. 2021. PMID: 33665078 Free PMC article.
A phase I/II study of osimertinib in EGFR exon 20 insertion mutation-positive non-small cell lung cancer.
Yasuda H, Ichihara E, Sakakibara-Konishi J, Zenke Y, Takeuchi S, Morise M, Hotta K, Sato M, Matsumoto S, Tanimoto A, Matsuzawa R, Kiura K, Takashima Y, Yano S, Koyama J, Fukushima T, Hamamoto J, Terai H, Ikemura S, Takemura R, Goto K, Soejima K. Yasuda H, et al. Lung Cancer. 2021 Dec;162:140-146. doi: 10.1016/j.lungcan.2021.10.006. Epub 2021 Oct 16. Lung Cancer. 2021. PMID: 34808485 Clinical Trial.
Effects of obesity on CC16 and their potential role in overweight/obese asthma.
Goudarzi H, Kimura H, Kimura H, Makita H, Matsumoto M, Takei N, Shimizu K, Suzuki M, Watanabe T, Kikuchi E, Ohira H, Tsujino I, Sakakibara-Konishi J, Shinagawa N, Shijubo N, Sato H, Shigehara K, Kaga K, Hida Y, Murakami S, Ebihara Y, Nakamura A, Miyoshi H, Hirano S, Hizawa N, Atsumi T, Huang SK, Ito YM, Nishimura M, Konno S. Goudarzi H, et al. Respir Res. 2022 Jun 29;23(1):174. doi: 10.1186/s12931-022-02038-1. Respir Res. 2022. PMID: 35768822 Free PMC article.
53 results